Evidence map›Paper›PMID 37274634›Full record

ReviewHeliyon2023

Global species diversity and distribution of the psychedelic fungal genus

Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Four New Species and a New Record ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Systematic study ofIMA fungus · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dominique StraussDepartment of Genetics, Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa.
Soumya GhoshDepartment of Genetics, Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa.
Zurika MurrayDepartment of Genetics, Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa.
Marieka GryzenhoutDepartment of Genetics, Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychedelic fungi have received considerable attention recently due to their promising treatment potential of several psychiatric disorders and medical conditions, both in clinical settings but also as a nutraceutical. Besides research, a growing number of companies are developing capacity to conduct research and clinical trials where these fungi and their products can be used, and to provide these fungi to the public market that are rapidly becoming legal across the world. Whereas

Indexed as

DNA sequenceGeographyHallucinogenicPanaeolusPsilocinPsilocybinTaxonomy

Identifiers

PMID37274634
PMCPMC10238702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.